Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 20.00
-0.30 (-1.48%)
Oct 5, 2026, 1:01 PM CET
Poltreg Market Cap
Poltreg has a market cap or net worth of 120.1 million as of October 2, 2026. Its market cap has increased by 4.69% in one year.
Market Cap
120.10M
Enterprise Value
104.94M
Revenue
240.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
ChartMarket Cap Chart
Since November 23, 2021, Poltreg's market cap has decreased from 289.09M to 120.10M, a decrease of -58.45%. That is a compound annual growth rate of -16.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 120.10M | 5.12% |
| Dec 30, 2025 | 114.25M | -33.06% |
| Dec 30, 2024 | 170.68M | -26.51% |
| Dec 29, 2023 | 232.24M | 8.26% |
| Dec 30, 2022 | 214.52M | -39.56% |
| Dec 30, 2021 | 354.90M | 22.77% |
| Nov 23, 2021 | 289.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 581.36M |
| Captor Therapeutics Spolka Akcyjna | 425.68M |
| Bioceltix | 406.62M |
| Ryvu Therapeutics | 358.36M |
| BIOTON | 326.71M |
| Synthaverse | 213.67M |
| Molecure | 145.87M |
| Mabion | 126.87M |